STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the revised $30.75 a share offer ...
Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 3.9% in the morning session after the company issued a statement to defend its pending merger process with Alcon against claims from ...
Alcon announced that it entered into an amended merger agreement for its planned acquisition of Staar Surgical.
The acrimonious $1.6 billion merger of STAAR Surgical Company (NASDAQ:STAA) and Alcon AG (NYSE:ALC) escalated again today as ...
The activist investor Broadwood, which owns 30.2% of Staar's stock, said it believes Staar is worth substantially more than the new, higher offer from Alcon. It said it would vote against the revised ...
STAAR Surgical's major shareholder intends to vote against the acquisition, stating the price still significantly undervalues ...
Alcon raises its Staar Surgical bid to $1.6B amid shareholder opposition, with a December 19 vote scheduled for acquisition.
(Corrects paragraph 5 to clarify vote has been postponed for third time, not previously postponed three times) By Maria ...
The conflict has now reached a binary choice for investors. STAAR CEO Stephen Farrell warned that the activist is attempting ...
Broadwood said it intends to seek the removal of Board Chair Elizabeth Yeu, Chief Executive Stephen Farrell and Arthur Butcher from Staar's board. Farrell became Staar's chief executive in February.
Shares of medical lens company STAAR Surgical (NASDAQ:STAA) fell 7.1% in the afternoon session after the company announced ...
STAAR Surgical ( STAA) soared 10% after Alcon ( ALC) increased its offer for STAAR to $30.75/share in cash. The purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results